Literature DB >> 23235933

[DGRW-Update: musculo-skeletal diseases].

B Greitemann1, S Dibbelt, S Fröhlich, C Niemeyer.   

Abstract

BACKGROUND: Orthopedic rehabilitation is a major entity in rehabilitation. Due to coming demographic changes and its challenges concerning mobility of elderly patients it will increase. The criticism on orthopedic rehabilitation in Germany focuses on its missing evidence in therapeutic eff ectiveness especially in chronic low back pain. This overall-criticism is actually no more valid as there are a number of studies showing eff ectiveness of orthopedic treatment in rehabilitation if psychosocial comorbidities are respected and treatment is focussed on occupational training and eintegration. GOALS: This overview describes the actual situation in orthopedic rehabilitation and its research.
RESULTS: The need for orthopedic rehabilitation will increase over the next years due to demographic changes. Important fi elds in orthopedic rehabilitation research are chronic low back pain, new rehabilitation models with focus on occupational reintegration, rehabilitation in elderly and following joint surgery as well as the analysis of health-care-system changes due to disease related groups. © Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Year:  2012        PMID: 23235933     DOI: 10.1055/s-0032-1327687

Source DB:  PubMed          Journal:  Rehabilitation (Stuttg)        ISSN: 0034-3536            Impact factor:   1.113


  3 in total

Review 1.  [Rehabilitation in orthopedics and trauma surgery. State of the art].

Authors:  B Kladny
Journal:  Orthopade       Date:  2013-10       Impact factor: 1.087

2.  [Inpatient and outpatient rehabilitation in Germany. Current state and further development].

Authors:  B Kladny
Journal:  Unfallchirurg       Date:  2015-02       Impact factor: 1.000

3.  [Acute inpatient multimodal pain therapy and rehabilitation: Framework conditions, tasks and differentiated patient allocation].

Authors:  B Arnold; H-R Casser; K Klimczyk; J Lutz; T Brinkschmidt; I Gralow; D Irnich; U Kaiser; B Nagel; M Schiltenwolf; M Pfingsten; R Sabatowski; W Söllner
Journal:  Schmerz       Date:  2015-12       Impact factor: 1.107

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.